Expanding a DTx Business from the EU to the US with Petter Aasa of Vitala

In this episode, you will discover: How continuous touch can help patients’ health improve continuously What the similarities and differences are between the EU and the US in the healthcare space Why healthcare companies should focus on preventive healthcare What Petter recommends for EU companies that plan to expand to the USKey Takeaways: Remote therapeutic monitoring codes came about with the belief that continuous touch with a patient during the course of their needs for exercise and therapy is going to help them progress instead of backsliding. This part of the process needs to be reimbursed to make sure that it is continually done and that the patient’s well-being continuously improves. The US and EU face similar challenges. Both markets don’t have a strong focus on preventive healthcare, focusing more on improving reactive measures. One difference is that the EU is very good at building innovation but is not good at supporting companies’ transition to adaptation which is why many EU companies migrate or expand to the US.Both the US and the EU market have a lot of incentive to focus on prevention: an aging population leading to a high prevalence of chronic diseases, rapidly increasing healthcare costs, and how diet, sleep, alcohol, and tobacco usage account for 90% of the total health determinants. Find the right regulatory and compliance partners because that is the hardest thing for a startup coming overseas to navigate through. Massive amounts of time, energy, and money can be saved by partnering with experts. “We're focusing on providing the best possible care for the patients while also solving a big problem for the providers, which has been that they don't have the right tools, energy, or the time to focus on prevention. They're stuck focusing on reactive treatments, which are fine, but it's not where the future is at.” - Petter AasaResources: Website: https://www.vitala.health/en/home LinkedIn: https://www.linkedin.com/in/petter-aasa-103245a9/ Learn more from Carrie and Rebecca: How NGL helps International Companies Enter the US Healthcare Market: https://nixongwiltlaw.com/internationalCase Study: https://nixongwiltlaw.com/case-study-antidote-healthHow NGL Helps DTx Companies Find a Path to Commercialization: https://nixongwiltlaw.com/digital-therapeutics Healthcare Insights (a monthly deep dive into specific topics for innovators): https://nixongwiltlaw.com/healthcare-insightsTelehealth/Virtual Care Mgmt Update (a biweekly LinkedIn newsletter tracking legal and policy changes across the nation): https://www.linkedin.com/newsletters/telehealth-virtual-care-update-6901900767960068096/ Website: https://nixongwiltlaw.com/  Carrie on LinkedIn: https://www.linkedin.com/in/carrienixon/ Rebecca on LinkedIn: https://www.linkedin.com/in/rebeccagwilt/NGL on LinkedIn: https://www.linkedin.com/company/nixon-gwilt-law/